Pharmaceutical Technology's In the Lab eNewsletter, November 2022

Single-use systems can benefit from standardized risk assessment and analysis protocols, which can facilitate the way in which processing equipment components are compared.

With the evolution of scalability of peripheral blood protein glycosylation, research has expanded for new biomarkers.

The newly formed partnership between CSafe and BioLife will expand cold chain supply chain solutions for the cell and gene therapy market.

Under the new collaboration with Tempus, GSK will have access to de-identified patient data to accelerate drug discovery, improve clinical trial design, and speed up enrollment.

Alexion’s acquisition of LogicBio is designed to accelerate the company’s growth in genomic medicines.

Eli Lilly and Company will partner with Schrödinger to develop and optimize small molecule compounds.

Cytiva’s acquisition of CEVEC Pharmaceuticals strengthens the company’s cell line development and biomanufacturing capabilities.

Freudenberg Medical’s Heflix TPE tubing is a high purity TPE intended for bioprocessing applications.